Clinical Trial Update: Methionine PET/CT Studies In Patients With Cancer [Phase 2]

View source ↗

Summary

Phase 2 methionine-based PET/CT imaging studies in patients with various cancers; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma
• Brain Tumors
• Ependymoma
• Hodgkin Lymphoma
• Low-grade Cns Tumors
• Medulloblastoma
• Non-hodgkin Lymphoma
• Osteosarcoma

Drugs mentioned

• Methionine (L-methionine) PET tracer (L-methionine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Brain Tumors and/or Solid Tumors Including, Brain Stem Glioma | Phase 2 | Status: ACTIVE_NOT_RECRUITING